Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $8.7900 (-6.34%) ($8.7900 - $8.7900) on Fri. Mar. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.77% (three month average) | RSI | 17 | Latest Price | $8.7900(-6.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -7.8% a day on average for past five trading days. | Weekly Trend | ATRA declines -16% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(50%) IBB(47%) ARKG(46%) ARKK(46%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -2.385% in a week (0% probabilities). VIXM(-43%) VXX(-32%) UNG(-19%) USO(-14%) UUP(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.385% (StdDev 4.77%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-15.27(-273.72%) | Resistance Level | $13.09 | 5 Day Moving Average | $10.19(-13.74%) | 10 Day Moving Average | $11.54(-23.83%) | 20 Day Moving Average | $13.09(-32.85%) | To recent high | -50.6% | To recent low | 0% | Market Cap | $653m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |